TMCnet News
Research and Markets: Neurology Drug Report 2014: Profiles of 480 Active Neurology Focused Drug Development CompaniesDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/3h43rh/neurology_drug) has announced the addition of the "Neurology Drug Report 2014" report to their offering. This report for the first time identifies and profiles 480 Active Neurology focused Drug Development companies from 31 countries worldwide, developing 801 neurological disorders targeting drugs. It evaluates 16 major neurological indications drug development pipeline and analysis it to provide thousands of active clinical trials information; emerging drug targets, molecule types etc. Thus all together brings the most updated and robust information at the fingertips. It creates immense authentic knowledge-base (all information with references) on hundreds of proprietary technologies, M&A deals and partnering occurring in domain in last 10 years. The 16 Major Indications detailed coverage in the report includes- Alzheimer's Disease, Parkinson's isease, Multiple Sclerosis, Schizophrenia, Major Depressive Disorder, Amyotrophic Lateral Sclerosis, Ischemic and Hemorrhagic Stroke, Huntington's Disease, Epilepsy, Pain (Migraine, Neurotropic and Post Hepatic Neuralgia), Neurological Trauma, Anxiety Disorders, ADHD, Addiction, Autism Spectrum (News - Alert) Disorder, Bipolar Disorder and other Rare Neurological disorder. Report covers each individual indication Epidemiology, Treatment options, Top selling drugs and their sales, indication Market size and forecast with detailed drug development Pipeline Analysis covering all Monoclonal Antibodies, Vaccines, Stem Cell Therapies, and Medical Devices in development, it also covers promising technologies and top drug development targets for the indication. Thus making it a versatile Comprehensive Report for Decision-Making. A Single Innovative and Unique Report provide Answers to Many:
For more information visit http://www.researchandmarkets.com/research/3h43rh/neurology_drug
|